Causality Determination in Pharmacovigilance

« Back to Previous Page
35
0

Clinical studies are only one source of safety data. How do biopharmas handle the flood of safety reports from healthcare...

Please to read the entire article.

Marked as spam
Posted by Norman Goldfarb (Discussions: 4, Comments: 0)
Replied on July 18, 2018 12:00 am
2 views
« Back to Previous Page